Xingyuan Jiao

Summary

Publications

  1. request reprint
    Jiao X, Huang J, Wu S, Lv M, Hu Y, Jianfu -, et al. hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int J Cancer. 2007;121:501-5 pubmed
    ..2, 95% CI = 0.8-4.0; hOGG1 326Cys/Cys:OR = 2.9, 95% CI = 0.6-29.4; p = 0.06, chi(2) tread test). These results suggest that hOGG1 Ser326Cys polymorphism is associated with gallbladder cancer risk. ..
  2. Huang Y, Chen G, Wang Y, He R, Du J, Jiao X, et al. Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma. Biochem Biophys Res Commun. 2018;503:1035-1041 pubmed publisher
  3. Zhang P, Guo Z, Hu R, He X, Jiao X, Zhu X. Interaction between microRNA-181a and TNFAIP1 regulates pancreatic cancer proliferation and migration. Tumour Biol. 2015;36:9693-701 pubmed publisher
    ..MiR-181a played a critical role in regulating pancreatic cancer growth and migration, likely interacting with TNFAIP1. ..
  4. Zhang P, Zhu X, Wu Y, Hu R, Li D, Du J, et al. Histone deacetylase inhibitors reduce WB-F344 oval cell viability and migration capability by suppressing AKT/mTOR signaling in vitro. Arch Biochem Biophys. 2016;590:1-9 pubmed publisher
    ..In conclusion, this study demonstrates that HDAC inhibitors affect oval cells by suppressing AKT/mTOR signaling. ..
  5. Jiao X, Ren J, Chen H, Ma J, Rao S, Huang K, et al. Ala499Val (C>T) and Lys939Gln (A>C) polymorphisms of the XPC gene: their correlation with the risk of primary gallbladder adenocarcinoma--a case-control study in China. Carcinogenesis. 2011;32:496-501 pubmed publisher
    ..The data from this case-control study indicated that XPC exonic variants contributed to the risk of GBC in this Chinese population. ..